PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

PTC Therapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2020 / 05:00PM GMT
Release Date Price: €43.6
Grant Watson;Jefferies;Analyst

Good afternoon. My name is Grant Watson, and I'm an analyst in the Jefferies Healthcare Investment Banking Department. It's my pleasure to introduce Stu Peltz, Founder and CEO at PTC Therapeutics, to present at the Jefferies Virtual Health Care Conference.

Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director

Thank you, and thanks for everyone coming. I appreciate it. So I'm going to tell you today about PTC Therapeutics, a company I started about 22 years ago now today. I just want to say that we will be making some forward-looking statements. So keep that in mind and look at our SEC filings.

So let's talk. So who's PTC? Who are we? We're a global commercial diversified biopharmaceutical company that's been focused on really discovering, developing, commercializing innovative therapies to treat rare genetic disorders. We started in New Jersey 22 years ago as an idea and have since over the 22 years built a global company around the world where the global

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot